Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma

Clinical Trial ID NCT00169195

PubWeight™ 0.80^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00169195

Top papers